Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 3 de 3
Filter
Add more filters











Database
Language
Publication year range
1.
Neurochem Res ; 37(12): 2826-35, 2012 Dec.
Article in English | MEDLINE | ID: mdl-23001398

ABSTRACT

Oxidative stress is implicated in brain damage associated with ischemia-reperfusion. Natural antioxidants found in some plants used in folk medicine have been indicated as potential neuroprotective agents. Here we investigated whether Trichilia catigua, a traditional Brazilian herbal medicine alleged to exhibit a variety of neuropharmacological properties (antidepressant, anti-neurasthenic, anti-inflammatory etc.), could have neuroprotective properties in rat hippocampal slices subjected to 2 h oxygen and glucose deprivation (OGD) followed by 1 h reperfusion. Ischemia-reperfusion (I/R) significantly decreased mitochondrial viability, increased dichlorofluorescein oxidation above control both in the incubation medium and slices homogenates, increased lactate dehydrogenase into the incubation medium and decreased non-protein thiols. T. catigua (40-100 µg/mL) protected slices from the deleterious effects of OGD when present before OGD and during the reperfusion periods. Oxidative stress in the medium was also determined under different conditions and the results demonstrated that T. catigua could not protect slices from I/R when it was added to the medium after ischemic insult. Although the translation to a real in vivo situation of I/R is difficult to be done, the results indicated that T. catigua should be used as preventive and not as a curative agent against brain damage.


Subject(s)
Hippocampus/drug effects , Meliaceae/chemistry , Oxidative Stress/drug effects , Plant Extracts/pharmacology , Reperfusion Injury/complications , Animals , Chromatography, High Pressure Liquid , Hippocampus/metabolism , In Vitro Techniques , Male , Rats , Rats, Wistar , Reperfusion Injury/metabolism
2.
Acta Pharm ; 62(3): 371-82, 2012 Nov.
Article in English | MEDLINE | ID: mdl-23470349

ABSTRACT

Antioxidant activity of the ethanolic extract and fractions from the stem bark of T. catigua was investigated. IC50 (for DPPH scavenging) by T. catigua varied from 9.17 ± 0.63 to 76.42 ± 5.87 mg mL⁻¹ and total phenolic content varied from 345.63 ± 41.08 to 601.27 ± 42.59 mg GAE g⁻¹ of dry extract. Fe²âº-induced lipid peroxidation was significantly reduced by the ethanolic extract and fractions. Mitochondrial Ca²âº-induced dichlorofluorescein oxidation was significantly reduced by the ethanolic extract in a concentration-dependent manner. Ethanolic extract reduced mitochondrial Δψm only at high concentrations (40-100 mg mL⁻¹), which indicates that its toxicity does not overlap with its antioxidant effects. Results suggest involvement of antioxidant activities of T. catigua in its pharmacological properties.


Subject(s)
Antioxidants/pharmacology , Meliaceae/chemistry , Plant Bark/chemistry , Plant Extracts/pharmacology , Plant Stems/chemistry , Animals , Antioxidants/analysis , Antioxidants/chemistry , Antioxidants/isolation & purification , Brain/drug effects , Brain/metabolism , Brazil , Ethnopharmacology , Flavonoids/analysis , Flavonoids/pharmacology , Lipid Peroxidation/drug effects , Male , Membrane Potential, Mitochondrial/drug effects , Mitochondria, Liver/drug effects , Mitochondria, Liver/metabolism , Osmolar Concentration , Phenols/analysis , Phenols/pharmacology , Plant Extracts/chemistry , Plant Extracts/isolation & purification , Rats , Rats, Wistar , Reactive Oxygen Species/antagonists & inhibitors , Reactive Oxygen Species/metabolism , Solvents/chemistry
3.
Molecules ; 15(11): 7699-714, 2010 Oct 28.
Article in English | MEDLINE | ID: mdl-21030914

ABSTRACT

Since the successful use of the organoselenium drug ebselen in clinical trials for the treatment of neuropathological conditions associated with oxidative stress, there have been concerted efforts geared towards understanding the precise mechanism of action of ebselen and other organoselenium compounds, especially the diorganyl diselenides such as diphenyl diselenide, and its analogs. Although the mechanism of action of ebselen and other organoselenium compounds has been shown to be related to their ability to generally mimic native glutathione peroxidase (GPx), only ebselen however has been shown to serve as a substrate for the mammalian thioredoxin reductase (TrxR), demonstrating another component of its pharmacological mechanisms. In fact, there is a dearth of information on the ability of other organoselenium compounds, especially diphenyl diselenide and its analogs, to serve as substrates for the mammalian enzyme thioredoxin reductase. Interestingly, diphenyl diselenide shares several antioxidant and neuroprotective properties with ebselen. Hence in the present study, we tested the hypothesis that diphenyl diselenide and some of its analogs (4,4'-bistrifluoromethyldiphenyl diselenide, 4,4'-bismethoxy-diphenyl diselenide, 4.4'-biscarboxydiphenyl diselenide, 4,4'-bischlorodiphenyl diselenide, 2,4,6,2',4',6'-hexamethyldiphenyl diselenide) could also be substrates for rat hepatic TrxR. Here we show for the first time that diselenides are good substrates for mammalian TrxR, but not necessarily good mimetics of GPx, and vice versa. For instance, bis-methoxydiphenyl diselenide had no GPx activity, whereas it was a good substrate for reduction by TrxR. Our experimental observations indicate a possible dissociation between the two pathways for peroxide degradation (either via substrate for TrxR or as a mimic of GPx). Consequently, the antioxidant activity of diphenyl diselenide and analogs can be attributed to their capacity to be substrates for mammalian TrxR and we therefore conclude that subtle changes in the aryl moiety of diselenides can be used as tool for dissociation of GPx or TrxR pathways as mechanism triggering their antioxidant activities.


Subject(s)
Antioxidants/metabolism , Benzene Derivatives/metabolism , Glutathione Peroxidase/metabolism , Mammals/metabolism , Organoselenium Compounds/metabolism , Thioredoxin-Disulfide Reductase/metabolism , Animals , Molecular Structure , Oxidation-Reduction
SELECTION OF CITATIONS
SEARCH DETAIL